Anxiety, Distress and Stress among Patients with Diabetes during COVID-19 Pandemic: A Systematic Review and Meta-Analysis

• Published in: Journal of personalized medicine Vol. 12; no. 9; p. 1412
• Main Authors: García-Lara, Rubén A., Gómez-Urquiza, José L., Membrive-Jiménez, María José, Velando-Soriano, Almudena, Granados-Bolivar, Monserrat E., Romero-Béjar, José L., Suleiman-Martos, Nora
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 30-08-2022; MDPI
• Subjects: Anxiety; Comorbidity; Coronaviruses; COVID-19; Diabetes mellitus; Mental depression; Mental disorders; Meta-analysis; Pandemics; Precision medicine; Review
• ISSN: 2075-4426; 2075-4426
• DOI: 10.3390/jpm12091412

The prevalence of mental health disorders has increased during the COVID-19 pandemic. Patients with chronic diseases, such as diabetes, are a particularly vulnerable risk group. This study aims to assess the levels and prevalence of anxiety, distress, and stress in patients with diabetes during the COVID-19 pandemic. A systematic review was conducted in CINAHL, Cochrane, LILACS, Medline, SciELO, and Scopus in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Thirty-seven articles with a total of 13,932 diabetic patients were included. Five meta-analyses were performed. The prevalence of anxiety was 23% (95% CI = 19–28) in T1DM and 20% (95% CI = 6–40) in T2DM patients. For diabetes distress it was 41% (95% CI = 24–60) for T1DM and 36% in T2DM patients (95% CI = 2–84). For stress, the prevalence was 79% (95% CI = 49–98) in T1DM patients. People with diabetes have significant psychiatric comorbidity as well as psychological factors that negatively affect disease management, increasing their vulnerability in an emergency situation. To establish comprehensive care in diabetic patients addressing mental health is essential, as well as including specific policy interventions to reduce the potential psychological harm of the COVID-19 pandemic.